Safety, Reactogenicity, and Health-Related Quality of Life After Trivalent Adjuvanted vs Trivalent High-Dose Inactivated Influenza Vaccines in Older Adults: A Randomized Clinical Trial

IMPORTANCE: Trivalent adjuvanted inactivated influenza vaccine (aIIV3) and trivalent high-dose inactivated influenza vaccine (HD-IIV3) are US-licensed for adults aged 65 years and older. Data are needed on the comparative safety, reactogenicity, and health-related quality of life (HRQOL) effects of...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmader, Kenneth E., Liu, Christine K., Harrington, Theresa, Rountree, Wes, Auerbach, Heidi, Walter, Emmanuel B., Barnett, Elizabeth D., Schlaudecker, Elizabeth P., Todd, Chris A., Poniewierski, Marek, Staat, Mary A., Wodi, Patricia, Broder, Karen R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809592/
https://www.ncbi.nlm.nih.gov/pubmed/33443580
http://dx.doi.org/10.1001/jamanetworkopen.2020.31266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809592/
https://www.ncbi.nlm.nih.gov/pubmed/33443580
http://dx.doi.org/10.1001/jamanetworkopen.2020.31266

Ejemplares similares